Related Experiment Video

Updated: May 15, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

[Gastrointestinal bleeding in liver cirrhosis at the ICU]

A Koch1, L Buendgens, H Dückers

  • 1Medizinische Klinik III, Universitätsklinikum Aachen.

Zeitschrift Fur Gastroenterologie
|January 15, 2013
PubMed

Insights

Patients with liver cirrhosis face high risks of severe gastrointestinal bleeding (GIB). The MELD score and mechanical ventilation independently predict mortality in these critical GIB cases, highlighting a poor prognosis.

Area of Science:

  • Gastroenterology and Hepatology
  • Critical Care Medicine
  • Epidemiology

Context:

  • Liver cirrhosis significantly increases the risk of severe gastrointestinal bleeding (GIB).
  • Patients with cirrhosis are frequently admitted to the intensive care unit (ICU) for GIB management.
  • Cirrhotic patients admitted to the ICU have a higher likelihood of developing GIB during their stay.

Purpose:

  • To identify epidemiological and prognostic factors for severe GIB in patients with liver cirrhosis.
  • To analyze the outcomes and risk factors associated with GIB in cirrhotic patients within an ICU setting.

Summary:

  • A retrospective analysis of 7376 ICU patients (1999-2010) found 650 (8.8%) had liver cirrhosis.
  • Cirrhosis was prevalent in ICU patients with severe GIB (23.2%) and those developing GIB during ICU care (40.9%).
  • Variceal and non-variceal hemorrhages were common; MELD score and mechanical ventilation were independent mortality predictors. Cirrhotic patients with GIB had a 26.1% fatality rate versus 6.8% for non-cirrhotics.

Impact:

  • Identifies MELD score and mechanical ventilation as key prognostic indicators for mortality in cirrhotic patients with severe GIB.
  • Demonstrates a significantly worse prognosis for cirrhotic patients experiencing severe GIB, particularly new-onset GIB during ICU treatment.
  • Underscores the urgent need for advanced therapeutic strategies to improve outcomes for this high-risk patient population.

More Related Videos

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...